Geopolitics Alpha

Is AbbVie a Buy After Its Latest Earnings Report?

Published . Updated .

Covered by 2 outlets: Yahoo Finance, The Motley Fool.

Who covered it: Center 1 · Not rated 1. How we rate outlets

Is AbbVie a Buy After Its Latest Earnings Report?

Behind a doubling in adjusted EPS sits a more modest picture -- and a dividend streak worth understanding.

Directly affected

  • ABBV AbbVie+11.4% 30d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that AbbVie belongs to, so it often moves with news about it.

  • LLY Eli Lilly and+21.6% 30d

    Eli Lilly and is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.

  • JNJ Johnson & Johnson+1.3% 30d

    Johnson & Johnson is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.

  • MRK Merck+3.2% 18d

    Merck is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.

  • ABT Abbott Laboratories+3.1% 30d

    Abbott Laboratories is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.

  • PFE Pfizer+9.9% 30d

    Pfizer is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
ABBV-2.71%-2.90%baseafter closeafter closeafter closeafter close
XLVNo price data for this ticker———————
LLYNo price data for this ticker———————
JNJNo price data for this ticker———————
MRKNo price data for this ticker———————
ABTNo price data for this ticker———————
PFENo price data for this ticker———————

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Is AbbVie a Buy After Its Latest Earnings Report? Yahoo Finance

Source: Yahoo Finance

This story

CompanyWhenMoveStatus
ABBVthree days earlier-2.90%final price
ABBVfive days earlier-2.71%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

How solid “Is AbbVie a Buy After Its Latest Earnings Report?” looks

25 out of 100

“Is AbbVie a Buy After Its Latest Earnings Report?” scores 25 out of 100. The score uses 2 sources.